In head and neck squamous cell carcinomas (HNSCC), overexpression of EGFR is associated with relapse after radiotherapy6 and can be used for selection of patients for hyperfractionated accelerated radiotherapy7. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.